106 related articles for article (PubMed ID: 8182010)
21. Pharmacokinetics of a clarithromycin suspension in infants and children.
Gan VN; Chu SY; Kusmiesz HT; Craft JC
Antimicrob Agents Chemother; 1992 Nov; 36(11):2478-80. PubMed ID: 1489191
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics of clarithromycin.
Rodvold KA
Clin Pharmacokinet; 1999 Nov; 37(5):385-98. PubMed ID: 10589373
[TBL] [Abstract][Full Text] [Related]
23. Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis.
Margaritis VK; Ismailos GS; Naxakis SS; Mastronikolis NS; Goumas PD
Am J Rhinol; 2007; 21(5):574-8. PubMed ID: 17999793
[TBL] [Abstract][Full Text] [Related]
24. Studies on the bioequivalence of different strengths of tablets containing clarithromycin.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):588-93. PubMed ID: 15497665
[TBL] [Abstract][Full Text] [Related]
25. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
[TBL] [Abstract][Full Text] [Related]
26. Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients.
Fouka E; Lamprianidou E; Arvanitidis K; Filidou E; Kolios G; Miltiades P; Paraskakis E; Antoniadis A; Kotsianidis I; Bouros D
Lung; 2014 Dec; 192(6):849-55. PubMed ID: 25016929
[TBL] [Abstract][Full Text] [Related]
27. In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.
Novelli A; Fallani S; Cassetta MI; Arrigucci S; Mazzei T
J Chemother; 2002 Dec; 14(6):584-90. PubMed ID: 12583550
[TBL] [Abstract][Full Text] [Related]
28. Use of an enzyme-linked immunosorbent assay to assess penetration of amoxicillin into lung secretions.
Hill SL; Burnett D; Lovering AL; Stockley RA
Antimicrob Agents Chemother; 1992 Jul; 36(7):1545-52. PubMed ID: 1510453
[TBL] [Abstract][Full Text] [Related]
29. The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin.
Boruchoff SE; Sturgill MG; Grasing KW; Seibold JR; McCrea J; Winchell GA; Kusma SE; Deutsch PJ
Clin Pharmacol Ther; 2000 Apr; 67(4):351-9. PubMed ID: 10801243
[TBL] [Abstract][Full Text] [Related]
30. [Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk].
Sedlmayr T; Peters F; Raasch W; Kees F
Geburtshilfe Frauenheilkd; 1993 Jul; 53(7):488-91. PubMed ID: 8370491
[TBL] [Abstract][Full Text] [Related]
31. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases.
Wood LG; Garg ML; Simpson JL; Mori TA; Croft KD; Wark PA; Gibson PG
Am J Respir Crit Care Med; 2005 Mar; 171(5):426-30. PubMed ID: 15579724
[TBL] [Abstract][Full Text] [Related]
32. Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis.
Saralaya D; Peckham DG; Hulme B; Tobin CM; Denton M; Conway S; Etherington C
J Antimicrob Chemother; 2004 Feb; 53(2):325-8. PubMed ID: 14729733
[TBL] [Abstract][Full Text] [Related]
33. Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones.
Malerczyk C; Kolbert M; Kinzig-Schippers M; Sörgel F; Machka K; Shah PM
J Chemother; 2004 Feb; 16(1):56-61. PubMed ID: 15078000
[TBL] [Abstract][Full Text] [Related]
34. Penetration of clarithromycin into human saliva.
Wüst J; Hardegger U
Chemotherapy; 1993; 39(5):293-6. PubMed ID: 8370320
[TBL] [Abstract][Full Text] [Related]
35. Ocular penetration of oral clarithromycin in humans.
Al-Sibai MB; Al-Kaff AS; Raines D; El-Yazigi A
J Ocul Pharmacol Ther; 1998 Dec; 14(6):575-83. PubMed ID: 9867340
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and comparative bioavailability study of two clarithromycin suspensions following administration of a single oral dose to healthy volunteers.
Zakeri-Milani P; Valizadeh H; Ghanbarzadeh S; Nemati M
Arzneimittelforschung; 2009; 59(8):429-32. PubMed ID: 19813467
[TBL] [Abstract][Full Text] [Related]
37. Clarithromycin clinical pharmacokinetics.
Fraschini F; Scaglione F; Demartini G
Clin Pharmacokinet; 1993 Sep; 25(3):189-204. PubMed ID: 8222460
[TBL] [Abstract][Full Text] [Related]
38. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Brian Houston J; Oosterhuis B; Bjerrum OJ; Grynkiewicz G; Alder J; Rowland M; Garner C
Eur J Pharm Sci; 2011 Jun; 43(3):141-50. PubMed ID: 21540108
[TBL] [Abstract][Full Text] [Related]
39. The response of patients with purulent bronchiectasis to antibiotics for four months.
Hill SL; Burnett D; Hewetson KA; Stockley RA
Q J Med; 1988 Feb; 66(250):163-73. PubMed ID: 3262882
[TBL] [Abstract][Full Text] [Related]
40. [Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone].
Hiratsuka T; Mukae H; Ihiboshi H; Ashitani J; Katoh S; Mashimoto H; Hirosako S; Mizobe T; Matsumoto M; Matsukura S
Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):482-7. PubMed ID: 9742869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
